Study will test Humira as potentially preventive treatment in Parkinson’s The trial will assess whether an existing treatment for autoimmune disorders can impede the emergence of Parkinson's symptoms. Hafler and his team have discovered the presence of inflammation in the spinal fluid — the liquid that surrounds the brain and spinal cord — of those with RBD. In addition, they found that blocking tumor necrosis factor-alpha (TNF), an inflammatory protein produced by the body’s immune cells, can potentially halt Parkinson’s development. https://parkinsonsnewstoday.com/news/yale-trial-may-mark-1st-step-preventive-treatment-parkinsons/
